[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fAL-1pn8FIRFAg6tIUsMryHGAXgzdtrsdk7JKtHVeAa8":8,"$frI-OiS_pR0L7qIXkKupqPqLxarVR2k8m7RD6kh9ggYA":55,"$fOhv2KGlq4I836dVKlR48R_Q03U-0KqSeh5yvO9YZlKI":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},56565,867383,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//HeqYrHAMogJyzvc1UGOXPKD5AIG36i3n.png","梁洪潮","新昌县中医院","中西医结合科","副主任医师",157,0,"紫杉醇与卡铂的安全用药指南——肺癌三期治疗关键细节解读","","https://ystcdn.venuertc.com/venue/AI/1e0d2e5d-593c-4237-8bbf-2c5221cbca52.jpg","\u003Cdiv class=\"paclitaxel-carboplatin-guide\">\n  \u003Ch2 id=\"material_title\" class=\"pcg-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">紫杉醇与卡铂的安全用药指南——肺癌三期治疗关键细节解读\u003C/h2>\n  \n  \u003Csection class=\"pcg-intro\">\n    \u003Cdiv class=\"pcg-bg\">\n      \u003Cp>提到紫杉醇和卡铂，很多做化疗的朋友都听过。这两种属于细胞毒性药物，在肿瘤系统中常见联用。它们的用药环节涉及剂型选择、给药时间、不良反应预防等一系列细节。今天我们就梳理出8个关键用药要点，帮助大家更安心、更规范地使用紫杉醇和卡铂。\u003C/p>\n    \u003C/div>\n  \u003C/section>  \n\n  \u003C!-- 01 剂型选择与正确使用 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 紫杉醇、卡铂的剂型与使用方式\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">💧\u003C/span>\n          \u003Cstrong>剂型说明：\u003C/strong>两者均为注射剂型，多为静脉滴注给药。临床上常见紫杉醇普通注射液、白蛋白结合型紫杉醇，卡铂为注射用无色澄明溶液。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🧴\u003C/span>\n          \u003Cstrong>正确用法：\u003C/strong>应由专业医疗人员严格按照方案配制和给药，滴速和总时长需遵循处方要求。不得自行更改注射部位、稀释比例、滴注时间等参数。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">📝\u003C/span>\n          \u003Cstrong>临床案例：\u003C/strong>某男性患者在肿瘤科接受化疗，按医嘱每周静脉滴注紫杉醇和卡铂，对滴注速度和浓度调整后更好耐受。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 给药时间与周期安排 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 给药时间与化疗周期安排\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">⏰\u003C/span>\n          \u003Cstrong>用药周期：\u003C/strong>紫杉醇和卡铂在多种方案中，典型为21天为1周期，一般连续使用多周期。部分老年人或耐受性较差者，依据功能或并发症调整方案（参考R. Ko et al., 2024）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">📅\u003C/span>\n          \u003Cstrong>每次给药时间：\u003C/strong>常用方案为紫杉醇于化疗日首日单独滴注，再接卡铂。每次静脉注射，通常需耗时1-3小时。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🔒\u003C/span>\n          \u003Cstrong>操作规范：\u003C/strong>务必保证间隔周期合理，不随意提前或延后。若出现特殊反应，由医生评估是否需调整下周期。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 预防性用药及过敏管理 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 过敏预防与处理细节\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">⚠️\u003C/span>\n          \u003Cstrong>紫杉醇的过敏预防：\u003C/strong>普通紫杉醇因溶剂含有蓖麻油，较易引起过敏反应。通常建议化疗前半小时静脉注射激素和抗组胺药物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">💊\u003C/span>\n          \u003Cstrong>白蛋白结合型紫杉醇：\u003C/strong>此剂型过敏发生率较低，一般无需激素预处理，但如有过敏史或警惕性反应，应与医师沟通。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">👨‍⚕️\u003C/span>\n          \u003Cstrong>卡铂的注意点：\u003C/strong>极个别患者用药时出现变态反应。首次用药需密切监测，发生异常反应立即停药并处理。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 剂量调整及特殊人群注意事项 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 剂量调整与特殊人群用药\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">👴\u003C/span>\n          \u003Cstrong>老年人：\u003C/strong>肾功能或骨髓功能随年龄下降，紫杉醇和卡铂需按体表面积、肾小球滤过率调整剂量。老年群体可选择低剂量、更长间隔的用药方案（Shota Omori et al., 2023）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🤰\u003C/span>\n          \u003Cstrong>孕妇和哺乳期：\u003C/strong>两药均属于高危药物，孕期、哺乳期禁用，如必需用药应权衡风险，并请医生严格评估。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">⚖️\u003C/span>\n          \u003Cstrong>肝肾功能异常者：\u003C/strong>肝损害者紫杉醇慎用或减量，肾功能异常者卡铂需调整剂量并监测肌酐清除率。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 不良反应识别与处理方案 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 不良反应管理及应对方法\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🩸\u003C/span>\n          \u003Cstrong>最常见副作用：\u003C/strong>紫杉醇、卡铂均易抑制骨髓，导致白细胞、血小板减少。需定期检查血常规，并依检查结果调整药量。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🤢\u003C/span>\n          \u003Cstrong>恶心呕吐：\u003C/strong>卡铂致中度恶心呕吐，预先应用止吐药可明显降低不适（Kaira et al., 2020）。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🥱\u003C/span>\n          \u003Cstrong>神经毒性：\u003C/strong>紫杉醇易致四肢麻木，需警惕症状加重。如感不适，须报告医师评估是否缓减或停药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🚨\u003C/span>\n          \u003Cstrong>处理意见：\u003C/strong>出现发热、皮疹、呼吸急促、剧烈呕吐或皮肤出血点，立即通知医护人员。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 药物相互作用与用药禁忌 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药物相互作用和禁忌事项\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">❌\u003C/span>\n          \u003Cstrong>不宜联用药物：\u003C/strong>紫杉醇不能与强CYP3A4抑制剂（如酮康唑）同时用药，否则会加剧不良反应。卡铂慎与阿米卡星、庆大霉素合用，避免肾毒性叠加。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🍷\u003C/span>\n          \u003Cstrong>酒精及草药：\u003C/strong>避免合用酒精、草药及补品，不明成分易影响药效及安全性。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🚫\u003C/span>\n          \u003Cstrong>主要禁忌：\u003C/strong>紫杉醇对已知严重过敏者忌用；卡铂对既往对铂类药物过敏或重度骨髓抑制、严重肾功能障碍者禁用。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 07 储存与药品安全 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存及安全注意\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🔒\u003C/span>\n          \u003Cstrong>储存方法：\u003C/strong>原装未开封放阴凉、避光处，保持2-8℃或室温（按说明书），切勿冷冻。配好后的药液应尽快使用，最长不超过24小时。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">📦\u003C/span>\n          \u003Cstrong>安全处理：\u003C/strong>用剩的药品和耗材需按化疗药品要求专门回收，不要随意丢弃。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">⌛\u003C/span>\n          \u003Cstrong>有效期管理：\u003C/strong>切记用药前核查有效期，勿用过期药物，避免疗效下降或安全风险。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 注意漏服与过量处理 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量的应急措施\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">⏳\u003C/span>\n          \u003Cstrong>漏服情况：\u003C/strong>化疗周期定期安排，一旦错过当次，应由医生重新制定方案，不可自作主张补药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🚑\u003C/span>\n          \u003Cstrong>过量危害：\u003C/strong>紫杉醇或卡铂过量可引发严重骨髓抑制、神经损伤、肾毒肝损，出现异常反应要立即就诊。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">⚡\u003C/span>\n          \u003Cstrong>正确做法：\u003C/strong>有任何疑似过量或误用，务必第一时间联系医生，不建议等待症状自愈。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 用药案例总结与小结 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 实际用药案例与核心提醒\u003C/h2>\n      \u003Cul class=\"pcg-list\">\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">👨‍⚕️\u003C/span>\n          \u003Cstrong>案例一：\u003C/strong>60岁男性，按医嘱每21天用药1次，每次均严格遵循滴注速度调整，未见严重不良反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">🙎\u003C/span>\n          \u003Cstrong>案例二：\u003C/strong>一位老年患者因骨髓耐受较差，将用药间隔由1周延长至3周，配合血常规监测，效果更佳。\n        \u003C/li>\n        \u003Cli>\n          \u003Cspan class=\"pcg-emoji\">👩‍⚕️\u003C/span>\n          \u003Cstrong>案例三：\u003C/strong>有患者治疗过程中蛋白结合型紫杉醇替代普通剂型，减少了过敏，整体耐受性更高。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"pcg-summary\">紫杉醇和卡铂的安全用药，需要关注剂型、时间、剂量、过敏预防、监测副作用、储存、禁忌与相互作用等各环节。最重要的是严格执行医嘱，出现任何异常第一时间就医处理。\u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 文献与专业来源 -->\n  \u003Csection class=\"pcg-section\">\n    \u003Cdiv class=\"pcg-section-bg\">\n      \u003Ch2 class=\"pcg-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 参考文献\u003C/h2>\n      \u003Col class=\"pcg-reference-list\">\n        \u003Cli>R. Ko, et al. (2024). A phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin for concurrent chemoradiotherapy in elderly patients (≥75 years) with unresectable locally advanced NSCLC: JCOG1914. \u003Cem>Annals of Oncology\u003C/em>.\u003C/li>\n        \u003Cli>Kaira, K., Mouri, A., Kato, S. et al. (2020). A phase II study of daily carboplatin plus irradiation followed by durvalumab for stage III non-small cell lung cancer patients with PS 2 up to 74 years old and patients with PS 0 or 1 from 75 years: NEJ039A. \u003Cem>BMC Cancer\u003C/em>, 20, 961.\u003C/li>\n        \u003Cli>Shota Omori, et al. (2023). A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≥75 years): NEJ039A. \u003Cem>2023 ESMO Congress\u003C/em>, abstr 1292MO.\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.paclitaxel-carboplatin-guide {\n  font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;\n  max-width: 800px;\n  margin: 20px auto 40px auto;\n  background: #fff;\n  border-radius: 14px;\n  box-shadow: 0 2px 10px rgba(100,140,160,0.04);\n  padding: 30px 22px 20px 22px;\n  color: #22323d;\n}\n.pcg-title {\n  font-size: 2.2em;\n  color: #316787;\n  letter-spacing: 1px;\n  margin-top: 0px;\n  margin-bottom: 32px;\n  border-bottom: 2px solid #daf3f7;\n  padding-bottom: 10px;\n  text-align: left;\n  background: linear-gradient(90deg, #e7f9ff 60%, #f4faff 90%);\n  border-radius: 10px 10px 0 0;\n  box-shadow: 0 1px 1px rgba(150,180,210,0.07);\n}\n.pcg-intro {\n  margin-bottom: 30px;\n  background: linear-gradient(90deg, #eaf4fb 60%, #fcfefe 100%);\n  border-radius: 8px;\n  box-shadow: 0 1px 2px #e6f0f5b8;\n  padding: 18px 20px 14px 20px;\n}\n.pcg-bg {\n  padding: 8px 10px 10px 10px;\n  background: linear-gradient(90deg, #f7fafc 80%, #eaf6fc 100%);\n  border-radius: 8px;\n}\n.pcg-section {\n  margin: 32px 0 0 0;\n}\n.pcg-section-bg {\n  background: linear-gradient(90deg, #f5fafd 65%, #e4f3fbaa 100%);\n  border-left: 6px solid #91b6ce;\n  padding: 18px 18px 10px 18px;\n  border-radius: 10px 7px 7px 10px;\n  margin-bottom: 18px;\n  position: relative;\n  min-height: 60px;\n}\n.pcg-section-title {\n  font-size: 1.23em;\n  font-weight: bold;\n  color: #245f81;\n  padding-bottom: 5px;\n  letter-spacing: 1px;\n  margin-bottom: 8px;\n  margin-top: 0px;\n  background: linear-gradient(90deg, #ecf5fa 50%, #f6ffff 100%);\n  padding: 8px 0 4px 6px;\n  border-radius: 6px;\n}\n.pcg-list {\n  margin: 0 0 8px 0;\n  padding: 0;\n  list-style: none;\n}\n.pcg-list li {\n  margin-top: 8px;\n  line-height: 1.8;\n  position: relative;\n  padding-left: 30px;\n  font-size: 1.05em;\n  color: #235d70;\n}\n.pcg-list li .pcg-emoji {\n  position: absolute;\n  left: 0px;\n  top: 6px;\n  font-size: 1.19em;\n  line-height: 1;\n}\n.pcg-reference-list {\n  font-size: 1em;\n  color: #4a677f;\n  margin: 0.7em 0 0.7em 13px;\n  padding: 0 0 0 16px;\n  line-height: 1.7;\n}\n.pcg-summary {\n  color: #224a5d;\n  background: #f9f2ff;\n  margin-top: 14px;\n  border-radius: 5px;\n  padding: 12px 12px 9px 15px;\n  font-size: 1.07em;\n  box-shadow: 0 1px 1px #e3eaf5;\n}\n@media (max-width: 650px) {\n  .paclitaxel-carboplatin-guide {\n    padding: 10px 5px 15px 5px;\n    font-size: 1em;\n  }\n  .pcg-title {font-size:1.1em;}\n  .pcg-section-bg, .pcg-intro, .pcg-bg {padding:9px 6px 7px 8px;}\n}\n\u003C/style>\n\n","\u003Cdiv class=\"paclitaxel-carboplatin-guide\">\n  \u003Ch2 id=\"material_title\" class=\"pcg-title\" style=\"color:",599,"2025-08-07 11:41:27","紫杉醇, 卡铂, 肺癌, 化疗, 安全用药, 不良反应预防, 药物相互作用, 剂量调整","本文提供紫杉醇与卡铂的安全使用指南，解析关键用药细节，预防不良反应，确保疗效提升。适用于肺癌患者及家属，助您从容应对化疗。","2025-08-08 09:48:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]